AbbVie gets the first global regulatory approval of SKYRIZI in Japan

AbbVie, a research-based global biopharmaceutical company, has announced that the Japanese Ministry of Health, Labour an...

March 27, 2019 | Wednesday | News
Lupin, YL Biologics receive PMDA approval for Etanercept biosimilar in Japan

Lupin has announced that YL Biologics Limited (YLB), a joint venture between Lupin’s subsidiary Lupin Atlantis Hol...

March 26, 2019 | Tuesday | News
Eisai starts Phase III clinical trial for Alzheimer's drug

Eisai Co., Ltd. has announced that a global Phase III clinical study (Clarity AD/Study 301) of BAN2401, an anti-amyloid ...

March 25, 2019 | Monday | News
Eisai to present latest research on Alzheimer's Disease / Dementia Pipeline

Eisai Co., Ltd. announced that a total of seven presentations highlighting the latest data on its Alzheimer's disease/de...

March 22, 2019 | Friday | News
Biotech firm Spiber to develop artificial hair

Japanese startup Spiber has recently announced initiation of a joint research and development project using Spiber&rsquo...

March 21, 2019 | Thursday | News
Ono Pharma, twoXAR announce drug discovery research collaboration

Ono Pharmaceutical Co., Ltd., a Japanese pharmaceutical research and development company, and twoXAR, Inc., a US based a...

March 19, 2019 | Tuesday | News
Blackstone to acquire AYUMI Pharmaceutical

Blackstone has announced that private equity funds managed by Blackstone have entered into a definitive agreement to acq...

March 18, 2019 | Monday | News
Shimadzu incorporates AI in new chromatograph series

Shimadzu's new Nexera UHPLC series with AI and IoT enhancements sets industry standard for intelligence, efficiency and ...

March 15, 2019 | Friday | News
Chugai’s Hemlibra receives approval for severe Hemophilia A

Chugai Pharmaceutical has announced that Roche received the decision from the European Commission confirming that Hemlib...

March 15, 2019 | Friday | News
Aprecia, CMIC to bring 3DP pharmaceutical products to Japan

Privately held Aprecia Pharmaceuticals, LLC (Aprecia) and CMIC CMO Co., LTD (CMIC CMO) have announced that both com...

March 15, 2019 | Friday | News
Fujifilm to acquire Biogen in a $890 M deal

FUJIFILM Corporation ("Fujifilm") announced that it has entered into an agreement to acquire Biogen (Denmark) Manufactur...

March 13, 2019 | Wednesday | News
FDA accepts NDA for Lemborexant to treat Insomnia

Eisai Co., Ltd. and Imbrium Therapeutics L.P., a clinical-stage biopharmaceutical company and operating subsidiary of Pu...

March 12, 2019 | Tuesday | News
Oncoceutics licenses rights for its anti-cancer compound to Ohara

US based Oncoceutics, Inc. has announced the outlicense of the rights to the company’s lead compound, ONC201, for ...

March 12, 2019 | Tuesday | News
In a first ever head-to-head biologic clinical study in Ulcerative Colitis Takeda's Entyvio demonstrates superior results compared to Humira

Takeda Pharmaceutical Company Limited has announced results from the Phase 3b head-to-head VARSITY study which demonstra...

March 11, 2019 | Monday | News
Akili, Shionogi to develop digital therapeutics in key Asian markets

Akili Interactive, digital medicine company creating prescription treatments for people living with cognitive dysfunctio...

March 11, 2019 | Monday | News
Santen to raise disease awareness during World Glaucoma Week

Santen Pharmaceutical Co., Ltd. (Santen) announced on March 8 that as part of its initiatives to increase publ...

March 8, 2019 | Friday | News
Eisai submits marketing authorization application for Insomnia drug

Eisai Co., Ltd. has announced that a marketing authorization application has been submitted in Japan for lemborexant, an...

March 7, 2019 | Thursday | News
Study: Inflammation in the brain enhances the side-effects of hypnotic medication

In a study recently published in the European Journal of Pharmacology researchers at Okayama University show h...

March 6, 2019 | Wednesday | News